期刊
FRONTIERS IN PEDIATRICS
卷 10, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fped.2022.844845
关键词
KMT5B; intellectual disability; developmental delay; de novo; macrocephaly
类别
资金
- Department of Human Genetics, Israeli Ministry of Health (MOH) Pilot Program
The role of lysine methyltransferases and demethylases in chromatin modification regulation is well-established. This study focuses on the association between deleterious variants in the KMT5B gene and developmental disorders such as global developmental delay and intellectual disability. Three unrelated patients with these disorders were found to have distinct de novo mutations in the KMT5B gene. The findings suggest that KMT5B should be considered as a potential gene for the differential diagnosis of neurodevelopmental disorders accompanied by macrocephaly and overgrowth.
The role of lysine methyltransferases (KMTs) and demethylases (KDMs) in the regulation of chromatin modification is well-established. Recently, deleterious heterozygous variants in KMT5B were implicated in individuals with intellectual disability (ID) and/or autism spectrum disorder. We describe three unrelated patients with global developmental delay (GDD) or ID, macrocephaly and additional features. Using whole exome sequencing, each of the probands was found to harbor a distinct de novo heterozygous disease-causing variant in KMT5B: c.541C > G (p.His181Asp); c.833A > T (p.Asn278Ile); or c.391_394delAAAG (p.Lys131GlufsTer6). We discuss herein their clinical presentations, and compare them to those of previously reported patients. Furthermore, using a three-dimensional computational model of the KMT5B protein, we demonstrate the predicted structural effects of the two missense variants. Our findings support the role of de novo missense and nonsense variants in KMT5B-associated GDD/ID, and suggest that this gene should be considered in the differential diagnosis of neurodevelopmental disorders accompanied by macrocephaly and/or overgrowth.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据